| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/05/2005 | EP1492536A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 01/05/2005 | EP1492534A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | EP1006110B8 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 01/05/2005 | CN1561341A Hydrolysis of [R(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183114C Quinoline derivatives and quinazoline derivatives |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/05/2005 | CN1182782C Synergistic herbicidal composition and method for preventing and control of weeds |
| 01/05/2005 | CN1182781C Synergistic herbicidal composition and method for preventing and control of weeds |
| 01/04/2005 | US6838562 Salt formation of creatine and orotic acid; water solubility, stability, bioavailability |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838464 Inhibitor of cyclin-dependent kinase |
| 01/04/2005 | US6838463 Pyrimidine compounds and their use |
| 01/04/2005 | US6838415 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 01/04/2005 | US6838414 Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 01/04/2005 | US6838128 Comprises chiral, nonracemic gamma-lactone tail |
| 01/04/2005 | CA2186015C Nicotinic acid derivatives and herbicides |
| 01/04/2005 | CA2147155C Amide derivatives |
| 12/30/2004 | US20040267014 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 12/30/2004 | US20040267011 Methods for synthesis of diarylmethanes |
| 12/30/2004 | US20040266798 intermediates in the preparation of derivatives which possess anti-cancer activity; synthesis of 4{N-[(6RS)-2-Methyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl]-N-(prop-2-ynyl)amino}benzoic acid |
| 12/30/2004 | US20040266789 Substituted amino carboxylic acids |
| 12/30/2004 | US20040266774 Amide compounds |
| 12/30/2004 | US20040266767 Compounds which modulate release of one or more of the aforementioned inflammatory cytokines |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266763 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 12/30/2004 | US20040266747 Long chain fatty alcohol substituents in antineoplastic agents |
| 12/30/2004 | US20040265248 Biphenylene compounds |
| 12/30/2004 | US20040265228 biomarkers for medicinal radioimaging such as Positron Emission Tomography; 4-Anilinoquinazolines |
| 12/29/2004 | WO2004113341A2 Fungicidal triazolopyrimidines |
| 12/29/2004 | WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | WO2004113307A1 Process for producing pyrimidin-4-one compound |
| 12/29/2004 | WO2004113306A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 12/29/2004 | WO2004113305A2 Diamino substituted quinazoline derivatives as promoters of smn2 |
| 12/29/2004 | WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1491201A1 Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides |
| 12/29/2004 | EP1490368A2 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents |
| 12/29/2004 | EP1490358A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 12/29/2004 | EP1226138B1 Fab i inhibitors |
| 12/29/2004 | EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 12/29/2004 | EP1204646B1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 12/29/2004 | EP1073643B1 New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 12/29/2004 | EP0994834A4 Ligated platinum group metal catalyst complex and improved process for catalytically converting alkanes to esters and derivatives thereof |
| 12/29/2004 | EP0826671B1 Heterocyclic amide compounds and medicinal use of the same |
| 12/29/2004 | CN1182127C Substituted 2-benzo [c] furanone compound, its preparing process and pharmaceutical composition containing same |
| 12/29/2004 | CN1182123C Substituted bicyclic derivatives useful as anticancer agents |
| 12/29/2004 | CN1181822C Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemia conditions |
| 12/29/2004 | CA2530461A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 12/29/2004 | CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | CA2528771A1 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 12/29/2004 | CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 12/28/2004 | US6835726 For therapy of viral infections, particularly human Cytomegalovirus infection |
| 12/28/2004 | US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 12/28/2004 | US6835216 Chain-breaking antioxidants |
| 12/28/2004 | CA2126072C Tri-substituted phenyl derivatives and processes for their preparation |
| 12/23/2004 | WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 12/23/2004 | WO2004111013A1 Hepatitis c virus inhibitors |
| 12/23/2004 | WO2004111011A2 Synthesis of 2-aryl pyrimidine 4-carboxylic acid amides |
| 12/23/2004 | WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 12/23/2004 | WO2004110452A1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 12/23/2004 | US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 12/23/2004 | US20040259891 Novel pyrimidon derivatives |
| 12/23/2004 | US20040259887 Cannabinoid receptor ligands and uses thereof |
| 12/23/2004 | US20040259885 Urea kinase inhibitors |
| 12/23/2004 | US20040259881 Nitrogenous heterocyclic compounds |
| 12/23/2004 | US20040259877 Inhibitors against the production and release of inflammatory cytokines |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040259870 Antidiabetic agents; obesity; controlling appetite |
| 12/23/2004 | US20040259865 Laxative; adenosine receptor antagonist |
| 12/23/2004 | US20040259826 Mitotic kinesin inhibitors |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/23/2004 | US20040258771 Reduced toxicity cisplatin formulations and methods for using the same |
| 12/23/2004 | DE10326186A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 12/23/2004 | CA2529090A1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 12/23/2004 | CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 12/23/2004 | CA2527851A1 Hepatitis c virus inhibitors |
| 12/23/2004 | CA2527832A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 12/22/2004 | EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 12/22/2004 | EP1487843A2 Substituted phenylacetic acids |
| 12/22/2004 | EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents |
| 12/22/2004 | EP1487805A1 Pyrimidine derivatives |
| 12/22/2004 | EP1487785A2 Novel florfenicol-type antibiotics |
| 12/22/2004 | EP1487404A1 Use of compatible solutes for inhibiting the release of ceramides |
| 12/22/2004 | CN1556804A 3-substituted-4-pyrimidone derivatives |
| 12/22/2004 | CN1181062C 2-phenoxy pyrimidine derivative and its use in treating disease |
| 12/21/2004 | US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders. |
| 12/21/2004 | US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects |
| 12/16/2004 | WO2004108710A1 4-pyrimidinyl quinazoline derivatives for use in the treatment of tumours |
| 12/16/2004 | WO2004108691A1 Improved production of rosuvastatin calcium salt |
| 12/16/2004 | WO2004108690A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 12/16/2004 | WO2004108664A2 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same |
| 12/16/2004 | WO2004108663A1 N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/16/2004 | WO2004087677A3 Pyrimidin-4-one derivatives and their use as p38 kinase modulators |
| 12/16/2004 | WO2004069791A3 Preparation of substituted quinazolines |
| 12/16/2004 | WO2004069145A3 Anticancer compounds, process for their preparation and pharmaceutical compositions containing them |